Barts and The London School of Medicine and Dentistry, part of Queen Mary, University of London, offers international levels of excellence in research and teaching while serving a population of unrivalled diversity amongst which cases of diabetes, hypertension, heart disease, TB, oral disease and cancers are prevalent, within east London and the wider Thames Gateway. Through partnership with our linked trusts, notably Barts and The London NHS Trust, and our associated University Hospital Trusts – Homerton, Newham, Whipps Cross and Queen’s (Romford) the School’s research and teaching is informed by an exceptionally wide ranging and stimulating clinical environment. At the heart of the School’s mission lies world class research, the result of a focused programme of recruitment of leading research groups from the UK and abroad and a £100 million investment in state-of-the-art facilities. Research is focused on translational research, cancer, cardiac, dentistry, inflammation, endocrinology/ metabolism, immunology and infectious diseases, genomics, neuroscience, gastroenterology, epidemiology and primary care.

The School is nationally and internationally recognised for research in these areas, reflected in the £40 million it attracts annually in research income. Its fundamental mission, with its partner NHS Trusts, and other partner organisations, such as CR-UK, is to ensure that that the best possible clinical service is underpinned by the very latest developments in scientific and clinical teaching, training and research.

The School is organised into the following Institutes:

• Institute of Cancer
• Institute of Cell and Molecular Science
• Institute of Health Sciences Education
• Institute of Dentistry
• William Harvey Research Institute
• Wolfson Institute of Preventive Medicine

The School is also home to the first Cancer Research UK Clinical Centre [new window] to be established which takes an innovative 'molecules to patient' approach to research.